Date Title Description PDF
07 Nov 2024 On P&L The Company releases the press release related to the first nine months 2024 financial results Download
07 Nov 2024 On P&L The Company releases the first nine months 2024 financial results presentation Download
24 Oct 2024 On corporate transactions ROVI completes the strategic review of its CDMO business Download
31 Jul 2024 On P&L The Company releases the press release related to the first half 2024 financial results Download
31 Jul 2024 On P&L The Company releases the first half 2024 financial results presentation Download

Pages

Date Title Description PDF
05 Nov 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted on 3 and 4 November Download
03 Nov 2021 On business and financial situation The Company releases the first nine months 2021 financial results presentation Download
03 Nov 2021 On business and financial situation The Company releases the press release related to the first nine months 2021 financial results Download
21 Oct 2021 Liquidity and counterparty agreements Download
21 Oct 2021 On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Download

Pages

Date Title Description PDF
17 Mar 2016 Acuerdos estratégicos con terceros Enervit Nutrition, joint venture of ROVI and Enervit, will distribute nutritional products in Spain and Portugal Download
24 Feb 2016 Información sobre resultados (2) ROVI releases the press release related to the full year 2015 results Download
24 Feb 2016 Información sobre resultados ROVI releases the press release related to the full year 2015 results Download
24 Feb 2016 Contratos de liquidez y contrapartida The Company informs that it has signed a liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. Download
24 Feb 2016 Informe Anual de Gobierno Corporativo 2015 ROVI releases the 2015 Annual Corporate Governance Report Download

Pages